At Confidio, we deliver client solutions that are meaningful, measurable, and sustainable. Confidio wants to keep you up-to-date about medications in development and medications that have been recently FDA approved.
Quarterly, we will provide a pipeline report to help clients anticipate medication trends and potential shifts in medication cost management.
On a quarterly basis, this report will outline:
- Executive Summary Takeaways
- Comments By Clinical Pharmacists: Place In Therapy Or Disease Population
- Recent FDA Drug Approvals & Brief of New Molecular Entity Approvals
- Medications in Development with Forecasted FDA Approval Dates
- Upcoming Specialty / Biosimilar Pipeline Therapies
- Existing FDA Approved Treatments within Therapy Class
- Cost Information When Available